首页> 美国卫生研究院文献>other >Maternal Serum Soluble CD30 Is Increased in Normal Pregnancy but Decreased in Preeclampsia and Small for Gestational Age Pregnancies
【2h】

Maternal Serum Soluble CD30 Is Increased in Normal Pregnancy but Decreased in Preeclampsia and Small for Gestational Age Pregnancies

机译:孕期孕妇血清可溶性CD30水平升高但子痫前期降低妊娠期妊娠小。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveWomen with preeclampsia and those who deliver small for gestational age (SGA) neonates are characterized by intravascular inflammation (T helper 1 (Th1)-biased immune response). There is controversy about the T helper 2 (Th2) response in preeclampsia and SGA. CD30, a member of the tumor necrosis factor receptor superfamily, is preferentially expressed in vitro and in vivo by activated T cells producing Th2-type cytokines. Its soluble form (sCD30) has been proposed to be an index of Th2 immune response. The objective of this study was to determine whether maternal serum concentration of sCD30 changes with normal pregnancy, as well as in mothers with preeclampsia and those who deliver SGA neonates.
机译:目的子痫前期妇女和胎龄小(SGA)新生儿的妇女的特征是血管内炎症(T辅助1(Th1)偏向免疫反应)。关于先兆子痫和SGA中的T辅助2(Th2)反应存在争议。 CD30是肿瘤坏死因子受体超家族的成员,在体内和体外优先通过产生Th2型细胞因子的活化T细胞表达。已经提出其可溶形式(sCD30)是Th2免疫应答的指标。这项研究的目的是确定孕妇的sCD30血清浓度是否随正常妊娠以及子痫前期母亲和分娩SGA的母亲而变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号